"Queen’s Cancer Center is your best choice for cancer care. Our comprehensive care program was established in Hawaii more than 40 years ago. Today, we continue to provide Hawaii’s patients with complete cancer care, from prevention to diagnosis and treatment, to survivorship. We offer cancer care in Honolulu, West Oahu and on Hawaii Island and provide a personalized, comprehensive approach to each patient’s unique diagnosis."

During the past decade, Queen's Cancer Institute at Queen's Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 41 clinical trials were completed, i.e. on average, 4100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen's Cancer Institute at Queen's Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 23 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen's Cancer Institute at Queen's Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Queen's Cancer Institute at Queen's Medical Center" are "Breast Cancer" (20 trials), "Prostate Cancer" (9 trials), "Lung Cancer" (6 trials), "Leukemia" (4 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "Queen's Cancer Institute at Queen's Medical Center" in a lesser frequency.

Most popular intervention types in "Queen's Cancer Institute at Queen's Medical Center" are "Drug" (49 trials), "Other" (20 trials), "Biological" (13 trials), "Radiation" (9 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (14 trials), "cyclophosphamide" (8 trials), "bevacizumab" (6 trials), "gemcitabine hydrochloride" (5 trials) and "paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Queen's Cancer Institute at Queen's Medical Center" are 37 trials for "All" genders, 15 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Queen's Cancer Institute at Queen's Medical Center". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Queen's Cancer Institute at Queen's Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Queen's Cancer Institute at Queen's Medical Center, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".